Burgos Jesús, Hevia Eduardo, Llombart-Blanco Rafael, García Vicente, de Santos Moreno María Teresa, Benlloch María, Mariscal Gonzalo, Barrios Carlos
Vithas Internacional, Madrid, Spain.
University of Navarra Clinic, Madrid, Spain.
Eur Spine J. 2025 May;34(5):1849-1860. doi: 10.1007/s00586-025-08831-y. Epub 2025 Apr 5.
This systematic review and meta-analysis aimed to comprehensively assess the medium- and long-term effects of PSF on respiratory function in patients with adolescent idiopathic scoliosis (AIS) through a systematic review and meta-analysis.
Four major databases were searched. Mean differences and differences with 95% confidence intervals (CIs) were calculated. The meta-analysis was performed using Review Manager version 5.4. The risk of bias was assessed using MINORS criteria. Random-effects meta-analyses were conducted across the follow-up periods. Subgroup and sensitivity analyses considered the magnitude of the curve correction.
Nineteen studies comprising 1413 patients treated with PSF were included. Meta-analyses found no significant differences in %FVC between pre- and post-PSF follow-up to 2 years (MD 0.40, 95%CI -1.65 to 2.45), around 5 years (MD 1.02, 95%CI -1.59 to 3.62), and 10 or more years (MD -2.90, 95%CI -5.98 to 0.18). No significant differences were found in %FEV1. Similarly, %TLC showed no significant difference at 2 years (MD -2.75, 95%CI -7.20 to 1.71). Short-term follow-up up to 1 year demonstrated some degree of pulmonary function loss for both %FVC (MD 12.37, 95%CI 6.72 to 18.03) and %FEV1 (MD 12.42, 95%CI 2.48 to 22.35).
This rigorous meta-analysis demonstrates that PSF does not enhance respiratory function in AIS patients in either the short- or long-term, as assessed using current static pulmonary metrics. Future studies should explore non-fusion alternatives and their effects on lung health.
本系统评价和荟萃分析旨在通过系统评价和荟萃分析全面评估后路脊柱融合术(PSF)对青少年特发性脊柱侧凸(AIS)患者呼吸功能的中长期影响。
检索了四个主要数据库。计算了平均差和95%置信区间(CI)的差值。使用Review Manager 5.4版进行荟萃分析。采用MINORS标准评估偏倚风险。在整个随访期内进行随机效应荟萃分析。亚组分析和敏感性分析考虑了曲线矫正的程度。
纳入了19项研究,共1413例接受PSF治疗的患者。荟萃分析发现,PSF术后2年(平均差0.40,95%CI -1.65至2.45)、5年左右(平均差1.02,95%CI -1.59至3.62)以及10年或更长时间(平均差-2.90,95%CI -5.98至0.18)的随访中,用力肺活量(%FVC)在术前和术后之间无显著差异。第1秒用力呼气容积(%FEV1)也无显著差异。同样,2年时肺总量(%TLC)无显著差异(平均差-2.75,95%CI -7.20至1.71)。长达1年的短期随访显示,%FVC(平均差12.37,95%CI 6.72至18.03)和%FEV1(平均差12.42,95%CI 2.48至22.35)均有一定程度的肺功能损失。
这项严格的荟萃分析表明,使用当前的静态肺指标评估,PSF在短期或长期内均未改善AIS患者的呼吸功能。未来的研究应探索非融合替代方案及其对肺部健康的影响。